Vanguard Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.46B | Buy |
31,441,258
+617,775
| +2% | +$116M | 0.09% | 191 |
|
|
2025
Q3 | $4.84B | Buy |
30,823,483
+247,667
| +0.8% | +$38.3M | 0.07% | 267 |
|
|
2025
Q2 | $5.14B | Sell |
30,575,816
-163,979
| -0.5% | -$24.3M | 0.08% | 228 |
|
|
2025
Q1 | $4.24B | Sell |
30,739,795
-32,444
| -0.1% | -$4.14M | 0.08% | 259 |
|
|
2024
Q4 | $3.64B | Sell |
30,772,239
-20,738
| -0.1% | -$2.42M | 0.06% | 298 |
|
|
2024
Q3 | $3.4B | Buy |
30,792,977
+175,103
| +0.6% | +$18.3M | 0.06% | 315 |
|
|
2024
Q2 | $3.01B | Sell |
30,617,874
-2,405
| -0% | -$245K | 0.06% | 325 |
|
|
2024
Q1 | $3.43B | Sell |
30,620,279
-645,761
| -2% | -$69.7M | 0.07% | 298 |
|
|
2023
Q4 | $3.15B | Sell |
31,266,040
-825,805
| -3% | -$81.9M | 0.07% | 301 |
|
|
2023
Q3 | $2.79B | Sell |
32,091,845
-711,879
| -2% | -$64.4M | 0.07% | 296 |
|
|
2023
Q2 | $3.1B | Buy |
32,803,724
+61,275
| +0.2% | +$5.18M | 0.07% | 284 |
|
|
2023
Q1 | $2.47B | Buy |
32,742,449
+1,422,245
| +5% | +$107M | 0.06% | 341 |
|
|
2022
Q4 | $2.41B | Sell |
31,320,204
-831,365
| -3% | -$63.2M | 0.07% | 328 |
|
|
2022
Q3 | $2.14B | Sell |
32,151,569
-1,452,788
| -4% | -$92.1M | 0.06% | 338 |
|
|
2022
Q2 | $1.76B | Sell |
33,604,357
-131,543
| -0.4% | -$7.48M | 0.05% | 403 |
|
|
2022
Q1 | $1.91B | Sell |
33,735,900
-2,105,718
| -6% | -$113M | 0.05% | 435 |
|
|
2021
Q4 | $1.85B | Sell |
35,841,618
-1,052,283
| -3% | -$51.6M | 0.04% | 460 |
|
|
2021
Q3 | $1.82B | Buy |
36,893,901
+1,151,050
| +3% | +$62.4M | 0.05% | 450 |
|
|
2021
Q2 | $2.04B | Sell |
35,742,851
-365,777
| -1% | -$21.4M | 0.05% | 413 |
|
|
2021
Q1 | $2.19B | Buy |
36,108,628
+398,193
| +1% | +$22M | 0.06% | 359 |
|
|
2020
Q4 | $1.91B | Sell |
35,710,435
-146,014
| -0.4% | -$7.58M | 0.06% | 372 |
|
|
2020
Q3 | $1.68B | Sell |
35,856,449
-350,230
| -1% | -$18M | 0.06% | 360 |
|
|
2020
Q2 | $1.89B | Sell |
36,206,679
-395,502
| -1% | -$20.4M | 0.07% | 312 |
|
|
2020
Q1 | $1.75B | Buy |
36,602,181
+974,953
| +3% | +$50.6M | 0.07% | 264 |
|
|
2019
Q4 | $1.8B | Sell |
35,627,228
-860,513
| -2% | -$44.4M | 0.06% | 351 |
|
|
2019
Q3 | $1.72B | Buy |
36,487,741
+687,051
| +2% | +$31.4M | 0.06% | 337 |
|
|
2019
Q2 | $1.69B | Buy |
35,800,690
+622,563
| +2% | +$28.7M | 0.06% | 340 |
|
|
2019
Q1 | $1.69B | Buy |
35,178,127
+6,245,904
| +22% | +$313M | 0.07% | 318 |
|
|
2018
Q4 | $1.29B | Buy |
28,932,223
+910,273
| +3% | +$47.4M | 0.06% | 363 |
|
|
2018
Q3 | $1.51B | Buy |
28,021,950
+5,058,369
| +22% | +$259M | 0.06% | 374 |
|
|
2018
Q2 | $1.12B | Buy |
22,963,581
+1,137,213
| +5% | +$64.5M | 0.05% | 452 |
|
|
2018
Q1 | $1.37B | Sell |
21,826,368
-2,411,585
| -10% | -$165M | 0.06% | 378 |
|
|
2017
Q4 | $1.49B | Buy |
24,237,953
+173,280
| +0.7% | +$10.7M | 0.06% | 345 |
|
|
2017
Q3 | $1.61B | Buy |
24,064,673
+422,396
| +2% | +$29.9M | 0.08% | 292 |
|
|
2017
Q2 | $1.84B | Buy |
23,642,277
+440,967
| +2% | +$33.3M | 0.09% | 237 |
|
|
2017
Q1 | $1.89B | Buy |
23,201,310
+843,212
| +4% | +$66.4M | 0.1% | 216 |
|
|
2016
Q4 | $1.61B | Buy |
22,358,098
+419,863
| +2% | +$30.4M | 0.09% | 236 |
|
|
2016
Q3 | $1.7B | Sell |
21,938,235
-5,362
| -0% | -$433K | 0.1% | 209 |
|
|
2016
Q2 | $1.71B | Buy |
21,943,597
+3,022
| +0% | +$241K | 0.11% | 198 |
|
|
2016
Q1 | $1.8B | Buy |
21,940,575
+869,675
| +4% | +$70.7M | 0.12% | 169 |
|
|
2015
Q4 | $1.88B | Buy |
21,070,900
+474,654
| +2% | +$40.3M | 0.13% | 151 |
|
|
2015
Q3 | $1.58B | Buy |
20,596,246
+112,579
| +0.5% | +$9.41M | 0.11% | 169 |
|
|
2015
Q2 | $1.71B | Buy |
20,483,667
+149,705
| +0.7% | +$13.2M | 0.12% | 169 |
|
|
2015
Q1 | $1.84B | Buy |
20,333,962
+60,199
| +0.3% | +$5.18M | 0.12% | 161 |
|
|
2014
Q4 | $1.64B | Buy |
20,273,763
+298,177
| +1% | +$23.5M | 0.12% | 170 |
|
|
2014
Q3 | $1.5B | Buy |
19,975,586
+336,608
| +2% | +$24.5M | 0.12% | 169 |
|
|
2014
Q2 | $1.35B | Buy |
19,638,978
+318,650
| +2% | +$21.7M | 0.11% | 195 |
|
|
2014
Q1 | $1.35B | Buy |
19,320,328
+368,626
| +2% | +$25.6M | 0.11% | 174 |
|
|
2013
Q4 | $1.27B | Buy |
18,951,702
+738,438
| +4% | +$45.1M | 0.11% | 175 |
|
|
2013
Q3 | $950M | Buy |
18,213,264
+325,818
| +2% | +$16.6M | 0.09% | 228 |
|
|
2013
Q2 | $844M | Buy |
+17,887,446
| New | +$817M | 0.09% | 232 |
|
Other funds holding CAH
Vanguard Group's CAH Position: Q4 2025 in Review
Vanguard Group increased its Cardinal Health (CAH) stake by 2% in Q4 2025, buying an estimated $116M and bringing the position to 31,441,258 shares worth $6.46B. The position accounts for 0.09% of the portfolio, ranked #191.
Vanguard Group first reported a position in CAH in Q2 2013 and has held it in 51 quarters since. 1,405 funds tracked by Wall St. Rank hold CAH as of Q4 2025.
- Vanguard Group held 31,441,258 shares of Cardinal Health worth $6.46B as of Q4 2025.
- Vanguard Group bought 617,775 Cardinal Health shares in Q4 2025, an estimated $116M.
- Cardinal Health made up 0.09% of Vanguard Group's portfolio in Q4 2025, its #191 holding.
- Vanguard Group first reported a position in Cardinal Health in Q2 2013 and has held it in 51 quarters since.
- 1,405 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.